AI assistant
IRIDEX CORP — Director's Dealing 2013
Nov 8, 2013
34978_dirs_2013-11-08_1a59704d-ec33-4fd9-962b-36dd8fa3b39e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2013-11-05
Reporting Person: NAUMANN-ETIENNE RUEDIGER (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-05 | Common Stock | J | 64019 | — | Disposed | 0 | Indirect |
| 2013-11-05 | Common Stock | A | 9707 | — | Acquired | 9707 | Direct |
| 2013-11-05 | Common Stock | A | 638 | — | Acquired | 638 | Indirect |
Footnotes
F1: Transactions reported on this form represent pro rata distributions, and not a purchase or sale, of securities by Intertec Healthcare Partners, to their respective general, limited partners, and members without consideration.
F2: The Reporting Person is a general partner of Intertec Healthcare Partners LP ("Intertec") and may be deemed to share voting and dispositive power of the shares held by Intertec. The Reporting Person disclaims beneficial ownership of the shares held by Intertec, except to the extent of his proportionate partnership interest therein.